Author

Benedict C. S. Cross

Observed names: Bcs Cross, Bendict CS Cross, Benedict C S Cross, Benedict C. Cross, Benedict C.S. Cross, Benedict CS Cross, Benedict Cross, Benedict C.S. Cross, Benedict C. S. Cross, Cross, B. C. S, Cross, B.C.S., Cross, Benedict C. S.

Observed institutions: University of Cambridge, University of Manchester, National Institute for Health and Care Research, Horizon Discovery (United Kingdom), Addenbrooke's Hospital, NIHR Cambridge Biomedical Research Centre

ORCID: 0000-0003-1065-3139

Observed ORCID: 0000-0003-1065-3139

OpenAlex ID: A5011709620

The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule

2012 · Benedict C. S. Cross, Peter J. Bond, et al. · Proceedings of the National Academy of Sciences · 600

Delivering proteins for export from the cytosol

2009 · Benedict C. S. Cross, Irmgard Sinning, et al. · Nature Reviews Molecular Cell Biology · 195

Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum

2009 · Benedict C. S. Cross, Craig McKibbin, et al. · Journal of Cell Science · 112

Lifetime imaging of a fluorescent protein sensor reveals surprising stability of ER thiol redox

2013 · Edward Avezov, Benedict C.S. Cross, et al. · The Journal of Cell Biology · 107

PDF

RETRACTED: The Unfolded Protein Response Element IRE1α Senses Bacterial Proteins Invading the ER to Activate RIG-I and Innate Immune Signaling

2013 · Jin A. Cho, Ann-Hwee Lee, et al. · Cell Host & Microbe · 105

Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance

2017 · Carlos le Sage, Steffen Lawo, et al. · Scientific Reports · 55

PDF

Establishing a Flow Process to Coumarin‐8‐Carbaldehydes as Important Synthetic Scaffolds

2012 · Jaroslav Zak, David Ron, et al. · Chemistry - A European Journal · 45

Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors

2021 · Anita C. Bellail, Hong Ri Jin, et al. · Science Translational Medicine · 43

Specific transmembrane segments are selectively delayed at the ER translocon during opsin biogenesis

2008 · Nurzian Ismail, Samuel G. Crawshaw, et al. · Biochemical Journal · 43

PDF

Increasing the performance of pooled CRISPR–Cas9 drop-out screening

2016 · Benedict C. S. Cross, Steffen Lawo, et al. · Scientific Reports · 38

PDF

Selective inhibition of the unfolded protein response: targeting catalytic sites for Schiff base modification

2013 · Susana M Tomasio, Heather P Harding, et al. · Molecular BioSystems · 35

PDF

Dissecting the physiological role of selective transmembrane-segment retention at the ER translocon

2009 · Benedict C. S. Cross, Stephen High · Journal of Cell Science · 28

PDF

CRISPR: A Screener’s Guide

2019 · Carlos le Sage, Steffen Lawo, et al. · SLAS DISCOVERY · 22

The oligomeric state of Derlin-1 is modulated by endoplasmic reticulum stress

2007 · Samuel G. Crawshaw, Benedict C. S. Cross, et al. · Molecular Membrane Biology · 17

PDF

Positional editing of transmembrane domains during ion channel assembly

2012 · Karin Öjemalm, Helen R. Watson, et al. · Journal of Cell Science · 12

PDF

Endoplasmic reticulum-associated degradation of a degron-containing polytopic membrane protein

2009 · Arpita Ray-Sinha, Benedict C.S. Cross, et al. · Molecular Membrane Biology · 11

PDF

A Flexible, Pooled CRISPR Library for Drug Development Screens

2020 · Maximilian Blanck, Milka B. Budnik-Zawilska, et al. · The CRISPR Journal · 7

PDF

New twists in the unfolded protein response

2012 · Benedict C S Cross, David Ron · eLife · 4

PDF

Retraction Notice to: The Unfolded Protein Response Element IRE1α Senses Bacterial Proteins Invading the ER to Activate RIG-I and Innate Immune Signaling

2018 · Jin A. Cho, Ann-Hwee Lee, et al. · Cell Host & Microbe · 2

PDF

A Power-Up for Unbiased Screening with CRISPR

2018 · Benedict C. S. Cross · Genetic Engineering & Biotechnology News · 1

Abstract 409: Dual-direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance

2018 · Carlos le Sage, Steffen Lawo, et al. · Cancer Research · 1

Systematic molecular glue drug discovery with a high-throughput effector protein remodeling platform

2025 · Jia Lu, Kate Stuart, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PDF

Multimodal Screening—The Future of Drug Discovery and Development

2020 · Benedict C.S. Cross · Genetic Engineering & Biotechnology News

Abstract 3704: CRISPR screening in a xenograft model forin vivodrug moa analysis

2019 · Michele Melton, Athena Bast, et al. · Tumor Biology

Abstract 1213: RNA-based screens in primary human immune cells

2019 · Bronwyn Joubert, Cristina Ghirelli, et al. · Cancer Research

Works count: 37

Citation count: 1,483

H-index: 14

I10-index: 16